Embed presentation





















Bangladesh has experienced steady economic growth of around 6% annually and is considered an emerging Asian tiger. It has a large and young population, with 80% under 40 and 65% under 25. The global pharmaceutical market is valued at $962 billion, and Bangladesh's domestic pharma market has grown from $811 million in 2009 to over $1.1 billion in 2014. The top 10 pharmaceutical companies hold 70% of the Bangladesh market, led by Square Pharmaceuticals at 18.68% share. The top 10 molecules contribute 52% of the total market share in Bangladesh.



















